Paediatric pharmacology Flashcards

1
Q

Learning outcome

A
  • To be aware of differences in drug absorption in paediatric patients
  • To understand principles of prescribing in children (including use of the BNFc)
  • To know how medication pharmacodynamics changes with each phase of childhood
  • To identify problems associated with paediatric prescribing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Challenges in paediatric prescribing

A
  • Lack of acute dosage data
  • Lack of appropriate formulations
  • Difficulty detecting ADR
  • In utero exposure and transplacental transfer of drugs in post natal period
  • Different pharmacodynamics and pharmacokinetics
  • Breast fed infants affected by mothers medication
  • Lack of patient information
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Key points in paediatric prescribing

A
  • Keep it simple
  • Is the therapy needed and what’s the expected effect
  • Minimum length to be on medication
  • Monitoring efficacy and ADRs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Off label and unlicensed

A
  • Off label → licensed for human but not for use in children below certage age
  • Unlicensed → no license for human use in country
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Indications for off-label prescribing

A
  • Formulation administered via route not intended → capsule to serum
  • Medication used for an indication not intended
  • Medication used at different dose
  • Children below recommended age limit
  • Medicines without a license
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risks of off-label medications

A
  • Increased risk of ADRs and avoidable death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Prescribing in neonates and infants

A
  • More sensitive to drugs than adults → organ system immaturity
  • Higher risk of adverse drug reaction
  • Greater individual variability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Prescribing in early post-natal period

A
  • Rapid growth
  • Highly variable alterations in drug metabolism and elimination
  • Lower tolerance to ADRs
  • Higher incidence of therapeutic errors
    • Difficulty identifying efficacy and toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Prescribing in infancy

A
  • Body weight gain and rapid changes to body water composition
  • Alteration to bodyweight to surface ration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Prescribing in young adults

A
  • Increased metabolism and secretion
  • Around 30% of prescribed medications off label
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Prescribing in adolescence

A
  • Sexual development → major changes in body size and composition
  • Psychological changes and peer pressure → smoking, alcohol and illicit drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SSRIs

A
  • Paroxetine
  • Associated with x4 increase in suicide compared to placebo when treating depression
  • Drug used off label
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Oral medications in paediatrics

A
  • Reduced gastric acid and delayed gastric emptying
  • Reduced bioavailability in drugs with high hepatic clearance and first pass metabolism
  • Variability in drugs with enter-hepatic circulation → cyclosporin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Percutaneous medications in paediatrics

A
  • Enhanced in infants and children → especially damaged skin
    • Think steroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Rectal medications for paediatrics

A
  • Those vomiting or unwilling to take oral medications
  • Avoids first past metabolism
  • Significant variability, few preparation and trauma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Paediatric drug distribution

A
  • Newborns → high extracellular fluid volume (45%)
  • High variability in fat content with development
17
Q

Blood brain barrier in paediatrics

A
  • Not fully developed
  • Drugs and chemical have easy access to CNS
  • High sensitivity to drugs → CNS dysfunction and toxicity
18
Q

Drug elimination in paediatrics

A
  • Immature neonatal liver → slower hepatic elimination
  • Longer time to reach steady state
    • Same process in kidneys
19
Q

Hepatic metabolism in paediatrics

A
  • Very slow due to immaturity of metabolising enzymes
  • Reduced oxidation and glucuronidation
  • Interindividual differences in hepatic metabolism
  • Rapid metabolic activity from 1 month with adult activity from age 1
20
Q

Metabolic disturbances in paediatrics

A
  • Drug sensitivity increased by
    • Fever
    • Dehydration (lower hydration reserves)
    • Acidosis (decreased cellular penetration)